<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25330327</article-id><article-id pub-id-type="pmc">4199596</article-id><article-id pub-id-type="publisher-id">PONE-D-14-33394</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0109617</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Carbohydrate Metabolism</subject><subject>Protein Metabolism</subject></subj-group></subj-group></subj-group><subj-group><subject>Nutrition</subject><subj-group><subject>Diet</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Gastrointestinal Imaging</subject><subj-group><subject>Liver and Spleen Scan</subject></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Gastroenterology and Hepatology</subject><subj-group><subject>Liver Diseases</subject><subj-group><subject>Fatty Liver</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>The Potential of a High Protein-Low Carbohydrate Diet to Preserve Intrahepatic Triglyceride Content in Healthy Humans</article-title><alt-title alt-title-type="running-head">High-Protein Diet and Intrahepatic Triglyceride Content</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Martens</surname><given-names>Eveline A.</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gatta-Cherifi</surname><given-names>Blandine</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="author-notes" rid="fn1">
<sup>&#x000a4;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gonnissen</surname><given-names>Hanne K.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Westerterp-Plantenga</surname><given-names>Margriet S.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">
<addr-line>Department of Human Biology, Maastricht University, Maastricht, The Netherlands</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Wong</surname><given-names>Vincent</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>The Chinese University of Hong Kong, Hong Kong</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>eap.martens@maastrichtuniversity.nl</email></corresp><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: MSW-P EAM BG-C HKG. Performed the experiments: EAM HKG BG-C. Analyzed the data: EAM BG-C. Wrote the paper: EAM BG-C. Contributed to the interpretation of the data and reviewed the manuscript: MSW-P.</p></fn><fn id="fn1" fn-type="current-aff"><label>&#x000a4;</label><p>Current address: Group Energy Balance and Obesity, INSERM U862, Neurocentre Magendie, Bordeaux, France</p></fn></author-notes><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>16</day><month>10</month><year>2014</year></pub-date><volume>9</volume><issue>10</issue><elocation-id>e109617</elocation-id><history><date date-type="received"><day>11</day><month>8</month><year>2014</year></date><date date-type="accepted"><day>29</day><month>8</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014 Martens et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Martens et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Protein supplementation has been shown to reduce the increases in intrahepatic triglyceride (IHTG) content induced by acute hypercaloric high-fat and high-fructose diets in humans.</p></sec><sec><title>Objective</title><p>To assess the effect of a 12-wk iso-energetic high protein-low carbohydrate (HPLC) diet compared with an iso-energetic high carbohydrate-low protein (HCLP) diet on IHTG content in healthy non-obese subjects, at a constant body weight.</p></sec><sec><title>Design</title><p>Seven men and nine women [mean &#x000b1; SD age: 24&#x000b1;5 y; BMI: 22.9&#x000b1;2.1 kg/m<sup>2</sup>] were randomly allocated to a HPLC [30/35/35% of energy (En%) from protein/carbohydrate/fat] or a HCLP (5/60/35 En%) diet by stratification on sex, age and BMI. Dietary guidelines were prescribed based on individual daily energy requirements. IHTG content was measured by <sup>1</sup>H-magnetic resonance spectroscopy before and after the dietary intervention.</p></sec><sec><title>Results</title><p>IHTG content changed in different directions with the HPLC (CH<sub>2</sub>H<sub>2</sub>O: 0.23&#x000b1;0.17 to 0.20&#x000b1;0.10; IHTG%: 0.25&#x000b1;0.20% to 0.22&#x000b1;0.11%) compared with the HCLP diet (CH<sub>2</sub>H<sub>2</sub>O: 0.34&#x000b1;0.20 vs. 0.38&#x000b1;0.21; IHTG%: 0.38&#x000b1;0.22% vs. 0.43&#x000b1;0.24%), which resulted in a lower IHTG content in the HPLC compared with the HCLP diet group after 12 weeks, which almost reached statistical significance (<italic>P</italic>&#x0200a;=&#x0200a;0.055).</p></sec><sec><title>Conclusions</title><p>A HPLC vs. a HCLP diet has the potential to preserve vs. enlarge IHTG content in healthy non-obese subjects at a constant body weight.</p></sec><sec><title>Trial Registration</title><p>Clinicaltrials.gov <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/ct2/show/NCT01551238?term=NCT01551238&#x00026;rank=1">NCT01551238</ext-link>
</p></sec></abstract><funding-group><funding-statement>This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement n&#x000b0; 266408. BG-C was supported by grants from the French Society of Endocrinology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="5"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec id="s1"><title>Introduction</title><p>Energy-restricted high-protein diets are commonly applied as interventions aiming to induce body weight loss and related improvements in metabolic profile <xref rid="pone.0109617-Acheson1" ref-type="bibr">[1]</xref>, <xref rid="pone.0109617-Wycherley1" ref-type="bibr">[2]</xref>. On the other hand, high carbohydrate-high fat diets may increase the susceptibility for overeating, which may result in the development of metabolic disturbances <xref rid="pone.0109617-Westerterp1" ref-type="bibr">[3]</xref>, <xref rid="pone.0109617-Westerterp2" ref-type="bibr">[4]</xref>, <xref rid="pone.0109617-Stubbs1" ref-type="bibr">[5]</xref>. Visceral adipose tissue (VAT) volume has been linked to the metabolic disturbances associated with obesity, such as a diminished insulin sensitivity and dyslipidemia <xref rid="pone.0109617-Despres1" ref-type="bibr">[6]</xref>. However, high ectopic lipid content, especially intrahepatic triglyceride (IHTG) content, and not VAT volume, is an independent risk factor for these metabolic disturbances <xref rid="pone.0109617-Lettner1" ref-type="bibr">[7]</xref>, <xref rid="pone.0109617-Fabbrini1" ref-type="bibr">[8]</xref>, <xref rid="pone.0109617-Magkos1" ref-type="bibr">[9]</xref>. In obese subjects, increases in BMI, total adipose tissue volume, or VAT volume were only associated with increases in insulin resistance and disturbances in very-low-density lipoprotein (VLDL)-TG metabolism when IHTG content was increased simultaneously <xref rid="pone.0109617-Magkos1" ref-type="bibr">[9]</xref>. Furthermore, insulin sensitivity was lower and VLDL secretion was higher in obese subjects with a high IHTG content (&#x0003e;5.5% of liver volume), matched on VAT volume <xref rid="pone.0109617-Fabbrini1" ref-type="bibr">[8]</xref>. No differences were observed between subjects with a high VAT volume (&#x0003e;1 100 cm<sup>3</sup>) but similar IHTG content <xref rid="pone.0109617-Fabbrini1" ref-type="bibr">[8]</xref>. Therefore, measuring IHTG content as a marker of metabolic function in dietary intervention studies is highly relevant.</p><p>Several human studies suggest that high protein intake may modulate IHTG content. A 4-wk uncontrolled study showed that protein supplementation was associated with a reduction in IHTG content in obese subjects <xref rid="pone.0109617-Bortolotti1" ref-type="bibr">[10]</xref>. In two short-term dietary intervention studies, protein supplementation reduced the increases in IHTG content induced by hypercaloric high-fat and high-fructose diets in healthy subjects <xref rid="pone.0109617-Bortolotti2" ref-type="bibr">[11]</xref>, <xref rid="pone.0109617-Theytaz1" ref-type="bibr">[12]</xref>. However, the longer-term effects of dietary protein content on IHTG content, thereby excluding the possible effects of metabolic disturbances and changes in body weight are unknown. Therefore, in the context of prevention of metabolic disturbances, the aim of this dietary intervention study was to assess the effect of a 12-wk iso-energetic high protein-low carbohydrate (HPLC) diet compared with an iso-energetic high carbohydrate-low protein (HCLP) diet on IHTG content in healthy non-obese subjects, at a constant body weight.</p></sec><sec sec-type="methods" id="s2"><title>Subjects and Methods</title><p>The Medical Ethical Committee of Maastricht University approved the study, and all subjects gave written informed consent. The study was registered on clinicaltrials.gov with Identifier: NCT01551238. The protocol for this trial and supporting CONSORT checklist are available as supporting information; see <xref ref-type="supplementary-material" rid="pone.0109617.s001">Checklist S1</xref> and <xref ref-type="supplementary-material" rid="pone.0109617.s002">protocol S1</xref>.</p><sec id="s2a"><title>Study subjects</title><p>Based on the study by Thetaz et al. <xref rid="pone.0109617-Theytaz1" ref-type="bibr">[12]</xref>, power analysis showed that with an &#x003b1; of 0.05 and a &#x003b2; of 0.80, at least 7 subjects per group were needed to show a difference in IHTG content between the dietary interventions of this study.</p><p>Twenty-four subjects were recruited by advertisements in local newspapers and on notice boards at the university. Data from measurements of four subjects were unreliable, and were therefore excluded from analysis. Four subjects had to be excluded from the data analysis because of non-compliance with the designated protein intake, as shown by the urinary nitrogen biomarker. The baseline characteristics of the excluded subjects did not differ from the total sample. Overall, 16 subjects (7 men and 9 women) were included in the final data analysis (<xref ref-type="fig" rid="pone-0109617-g001">
<bold>Figure 1</bold>
</xref>).</p><fig id="pone-0109617-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0109617.g001</object-id><label>Figure 1</label><caption><title>Flow diagram (CONSORT).</title><p>HCLP, high-carbohydrate low-protein; HPLC, high-protein low-carbohydrate.</p></caption><graphic xlink:href="pone.0109617.g001"/></fig><p>Subjects underwent a screening that included anthropometric measurements and the completion of questionnaires eliciting information about health, smoking behaviour, use of medications, and alcohol consumption. Subjects were aged between 19 and 31 y had a BMI between 19.0 and 25.3 kg/m<sup>2</sup>. Age and BMI were equally divided between males and females. Subjects were non-smoking, not using more than moderate amounts of alcohol (&#x0003e;10 drinks/wk), were weight stable (body weight change &#x0003c;3 kg during the last 6 mo and had no planned weight change during the study period), and were not using medication or supplements except for oral contraceptives in women.</p><p>The validated Dutch translation of the Baecke Activity Questionnaire was used to measure habitual physical activity scores, which were converted into a standardized individual physical activity level <xref rid="pone.0109617-Baecke1" ref-type="bibr">[13]</xref>, <xref rid="pone.0109617-Philippaerts1" ref-type="bibr">[14]</xref>.</p></sec><sec id="s2b"><title>Dietary intervention</title><p>The study used a single-blind parallel design in which subjects were randomly allocated to the HPLC [30/35/35% of energy (En%) from protein/carbohydrate/fat] or the HCLP (5/60/35 En%) diet following stratification on sex, age and BMI. Detailed dietary guidelines were prescribed based on individual daily energy requirements, calculated as the basal metabolic rate determined with the formula of Harris and Benedict <xref rid="pone.0109617-Harris1" ref-type="bibr">[15]</xref> times the physical activity level <xref rid="pone.0109617-Westerterp3" ref-type="bibr">[16]</xref>. This was carried out in order to keep body weight constant. Moreover, subjects were told that they were expected to maintain their body weight and physical activity level. The dietary guidelines included a variety of recipes for breakfasts, lunches, dinners and snacks, consisting of commercially available food items and the amounts that had to be consumed to reach the intended diet compositions. The guidelines included the prescription to consume additional protein [HPLC: whey with &#x003b1;-lactalbumin (Hiprotal Whey Protein Alpha, FrieslandCampina Domo EMEA, Amersfoort, The Netherlands)] or carbohydrate [HCLP: maltodextrin (Fantomalt, Nutricia, Zoetermeer, The Netherlands)] by shakes twice daily (<xref ref-type="table" rid="pone-0109617-t001">
<bold>Table 1</bold>
</xref>).</p><table-wrap id="pone-0109617-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0109617.t001</object-id><label>Table 1</label><caption><title>Sample menu for the HPLC and HCLP diets.</title></caption><alternatives><graphic id="pone-0109617-t001-1" xlink:href="pone.0109617.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">HPLC</td><td align="left" rowspan="1" colspan="1">HCLP</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>Breakfast</bold>
</td><td align="left" rowspan="1" colspan="1">Low-fat yoghurt</td><td align="left" rowspan="1" colspan="1">Whole-grain juice with forest fruits</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Breakfast cereals</td><td align="left" rowspan="1" colspan="1">Breakfast cereals</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Kiwi</td><td align="left" rowspan="1" colspan="1">Apple</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Semi-skimmed milk</td><td align="left" rowspan="1" colspan="1">Orange juice</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Lunch</bold>
</td><td align="left" rowspan="1" colspan="1">Whole-wheat bread</td><td align="left" rowspan="1" colspan="1">Whole-wheat bread</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Margarine</td><td align="left" rowspan="1" colspan="1">Margarine</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cheese spread</td><td align="left" rowspan="1" colspan="1">Apple spread</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Chicken breast</td><td align="left" rowspan="1" colspan="1">Hazelnut paste</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Snack</bold>
</td><td align="left" rowspan="1" colspan="1">Protein shake</td><td align="left" rowspan="1" colspan="1">Carbohydrate shake</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Dinner</bold>
</td><td align="left" rowspan="1" colspan="1">White rice</td><td align="left" rowspan="1" colspan="1">White rice</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">French beans</td><td align="left" rowspan="1" colspan="1">French beans</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Chicken breast</td><td align="left" rowspan="1" colspan="1">Red cabbage with apple</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Walnuts</td><td align="left" rowspan="1" colspan="1">Red pepper</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Olive oil</td><td align="left" rowspan="1" colspan="1">Olive oil</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Savoury sauce</td><td align="left" rowspan="1" colspan="1">Savoury sauce</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Snack</bold>
</td><td align="left" rowspan="1" colspan="1">Protein shake</td><td align="left" rowspan="1" colspan="1">Carbohydrate shake</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cereal bar</td><td align="left" rowspan="1" colspan="1">Corn crisps</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Apple</td><td align="left" rowspan="1" colspan="1">Pear</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>The amounts that were prescribed to consume were based on individual daily energy requirements.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2c"><title>Body weight and biomarker of protein intake</title><p>At baseline and at weeks 5, 9 and 12, body weight was measured by using a digital balance in order to check whether it remained constant, and 24-h urinary nitrogen excretion was determined as biomarker of protein intake throughout the intervention period.</p></sec><sec id="s2d"><title>IHTG content</title><p>MRI and proton magnetic resonance spectroscopy (<sup>1</sup>H-MRS) measurements were performed using a 1.5-T whole-body scanner (Intera; Philips Healthcare, Best, The Netherlands). Sagittal, coronal and transversal images through the right lobe in the lower third of the liver were obtained by MRI (slice thickness 8 mm; repetition time/echo time, 500/15 ms; matrix 180&#x000d7;96) in order to gain anatomical and positional information of the liver, <sup>1</sup>H-MRS enabled to measure IHTG content by distinguishing hepatic water from a spectrum of IHTG. Fatty acid chains that represent different proton moiety were separated by the relative magnitude of resonance <xref rid="pone.0109617-Hamilton1" ref-type="bibr">[17]</xref>. A 20&#x000d7;20&#x000d7;20 mm volume of interest was positioned, avoiding the lateral margin of the liver parenchyma, major blood vessels, and intrahepatic bile ducts. The position of the volume of interest was the same at the baseline measurement and at the measurement after the intervention. Following shimming (10&#x000d7;10&#x000d7;10 cm volume), eight spectra were acquired using a Q-body coil <xref rid="pone.0109617-Szczepaniak1" ref-type="bibr">[18]</xref>. Point-resolved spectroscopy sequence (PRESS) was used for spatial localization and signal acquisition using a protocol set up by Schrauwen-Hinderling et al (repetition time/echo time, 4000/33 ms; number of signals averaged fat/water, 64/16) <xref rid="pone.0109617-SchrauwenHinderling1" ref-type="bibr">[19]</xref>. Water signal was suppressed using 150 Hz frequency-selective prepulses. The unsuppressed water signal was measured in the same volume of interest under the same shimming conditions, and was used as a reference signal <xref rid="pone.0109617-SchrauwenHinderling1" ref-type="bibr">[19]</xref>. Spectra were fitted using the Java-based magnetic resonance user interface (jMRUI) package fitted in the domain using a non-linear least-squares algorithm (AMARES) <xref rid="pone.0109617-SchrauwenHinderling1" ref-type="bibr">[19]</xref>, <xref rid="pone.0109617-Naressi1" ref-type="bibr">[20]</xref>, <xref rid="pone.0109617-Vanhamme1" ref-type="bibr">[21]</xref>. Areas of resonance from protons of methylene [-(CH<sub>2</sub>)<sub>n</sub>-] and methyl (CH<sub>3</sub>) in the fatty acid chains, relative to the area of protons of H<sub>2</sub>O, were used as a measure for the IHTG content. A more extensive description of the applied post processing procedure has been published previously <xref rid="pone.0109617-Szczepaniak1" ref-type="bibr">[18]</xref>, <xref rid="pone.0109617-SchrauwenHinderling1" ref-type="bibr">[19]</xref>, <xref rid="pone.0109617-Vanhamme1" ref-type="bibr">[21]</xref>, <xref rid="pone.0109617-Boesch1" ref-type="bibr">[22]</xref>, <xref rid="pone.0109617-Schick1" ref-type="bibr">[23]</xref>.</p></sec><sec id="s2e"><title>Statistical analysis</title><p>All statistical analyses were performed by using SPSS version 20 for Macintosh OS X (SPSS Inc.). Differences in subject characteristics and anthropometrics between the diet groups were assessed using Factorial ANOVA. Mann-Whitney tests were used to test for differences in IHTG content between the diet groups.</p><p>Factorial ANOVAs with repeated measures were used to test whether nitrogen excretion, body weight, and BMI changed over time within the diet groups, and to test whether these effects differed between the diet groups. Data on IHTG content were log transformed before these statistical analyses were performed. Differences were regarded statistically significant if <italic>P</italic>&#x0003c;0.05. Data are presented as mean &#x000b1; SD.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Subject characteristics</title><p>Subject characteristics did not differ between the diet groups at baseline (<xref ref-type="table" rid="pone-0109617-t002">
<bold>Table 2</bold>
</xref>). No adverse events were reported.</p><table-wrap id="pone-0109617-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0109617.t002</object-id><label>Table 2</label><caption><title>Subject characteristics, anthropometrics and IHTG content in the HPLC and HCLP diet groups at baseline and after 12 weeks.</title></caption><alternatives><graphic id="pone-0109617-t002-2" xlink:href="pone.0109617.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="left" rowspan="1">Baseline</td><td colspan="2" align="left" rowspan="1">After 12 weeks</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">HPLC</td><td align="left" rowspan="1" colspan="1">HCLP</td><td align="left" rowspan="1" colspan="1">HPLC</td><td align="left" rowspan="1" colspan="1">HCLP</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>No. of subjects (M/F)</bold>
</td><td align="left" rowspan="1" colspan="1">7 (4/3)</td><td align="left" rowspan="1" colspan="1">9 (3/6)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Age (y)</bold>
</td><td align="left" rowspan="1" colspan="1">23&#x000b1;5</td><td align="left" rowspan="1" colspan="1">25&#x000b1;5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Baecke total score</bold>
</td><td align="left" rowspan="1" colspan="1">9.4&#x000b1;1.0</td><td align="left" rowspan="1" colspan="1">8.9&#x000b1;1.1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Height (cm)</bold>
</td><td align="left" rowspan="1" colspan="1">173&#x000b1;8</td><td align="left" rowspan="1" colspan="1">170&#x000b1;9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>BW (kg)</bold>
</td><td align="left" rowspan="1" colspan="1">67.6&#x000b1;6.6</td><td align="left" rowspan="1" colspan="1">64.5&#x000b1;8.2</td><td align="left" rowspan="1" colspan="1">67.8&#x000b1;6.2</td><td align="left" rowspan="1" colspan="1">64.3&#x000b1;7.5</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>BMI (kg/m<sup>2</sup>)</bold>
</td><td align="left" rowspan="1" colspan="1">22.6&#x000b1;2.0</td><td align="left" rowspan="1" colspan="1">22.3&#x000b1;2.1</td><td align="left" rowspan="1" colspan="1">22.7&#x000b1;2.3</td><td align="left" rowspan="1" colspan="1">22.2&#x000b1;2.0</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>IHTG content</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>CH<sub>2</sub>H<sub>2</sub>O</bold>
</td><td align="left" rowspan="1" colspan="1">0.23&#x000b1;0.17</td><td align="left" rowspan="1" colspan="1">0.34&#x000b1;0.20</td><td align="left" rowspan="1" colspan="1">0.20&#x000b1;0.10<xref ref-type="table-fn" rid="nt103">*</xref>
</td><td align="left" rowspan="1" colspan="1">0.38&#x000b1;0.21<xref ref-type="table-fn" rid="nt103">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>IHTG (%)</bold>
</td><td align="left" rowspan="1" colspan="1">0.25&#x000b1;0.20</td><td align="left" rowspan="1" colspan="1">0.38&#x000b1;0.22</td><td align="left" rowspan="1" colspan="1">0.22&#x000b1;0.11<xref ref-type="table-fn" rid="nt103">*</xref>
</td><td align="left" rowspan="1" colspan="1">0.43&#x000b1;0.24<xref ref-type="table-fn" rid="nt103">*</xref>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt102"><label/><p>Values represent numbers or means &#x000b1; SD.</p></fn><fn id="nt103"><label/><p>*Trend (<italic>P</italic>&#x0200a;=&#x0200a;0.055) for factorial ANOVA with repeated measures between diet groups.</p></fn><fn id="nt104"><label/><p>BW, body weight; HCLP, high-carbohydrate low-protein; HPLC, high-protein low-carbohydrate; IHTG, intrahepatic triglyceride.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><title>Body weight and biomarker of protein intake</title><p>The condition of stable body weight was met in both arms. Baseline nitrogen excretion did not differ significantly between the HPLC (12.2&#x000b1;3.6 g/d) and HCLP (11.4&#x000b1;3.4 g/d) diets. Nitrogen excretion increased significantly in the HPLC (23.3&#x000b1;4.4 g/d, <italic>P</italic>&#x0003c;0.05), and decreased in the HCLP (6.5&#x000b1;1.3 g/d, <italic>P</italic>&#x0200a;=&#x0200a;0.001) diet group compared with baseline. Significant differences in protein intake between the diet groups were confirmed in that nitrogen excretion differed significantly between the diet groups throughout the intervention period (<italic>P</italic>&#x0200a;=&#x0200a;0.001).</p></sec><sec id="s3c"><title>IHTG content</title><p>IHTG content decreased with the HPLC (CH<sub>2</sub>H<sub>2</sub>O: 0.23&#x000b1;0.17 to 0.20&#x000b1;0.10; IHTG%: 0.25&#x000b1;0.20% to 0.22&#x000b1;0.11%) and increased with the HCLP diet (CH<sub>2</sub>H<sub>2</sub>O: 0.34&#x000b1;0.20 vs. 0.38&#x000b1;0.21; IHTG%: 0.38&#x000b1;0.22% vs. 0.43&#x000b1;0.24%), although not reaching statistical significance (<xref ref-type="table" rid="pone-0109617-t002">Table 2</xref>). These changes of IHTG content in different directions resulted in a lower IHTG content in the HPLC compared with the HCLP diet group after 12 weeks, which almost reached statistical significance (<italic>P</italic>&#x0200a;=&#x0200a;0.055).</p></sec></sec><sec id="s4"><title>Discussion</title><p>Protein supplementation has been shown to reduce the increases in IHTG content induced by acute hypercaloric high-fat and high-fructose diets in humans. In the context of prevention of metabolic disturbances, we assessed the longer-term effects of iso-energetic diets with large contrasts in relative protein content on IHTG content in healthy non-obese subjects, thereby excluding the possible effects of changes in body weight. The present study showed that IHTG content changed in different directions with the HPLC compared with the HCLP diet, which resulted in a lower IHTG content in the HPLC compared with the HCLP diet group after 12 weeks, which almost reached statistical significance. The observation that the condition of stable body weight was met in both diet groups confirmed that this observation was not affected by changes in body weight. The successful implementation of the dietary intervention in each diet group was confirmed by urinary nitrogen concentrations.</p><p>A proposed mechanism for the modulation of IHTG content by a high protein intake is the stimulation of hepatic lipid oxidation due to the high energetic demand for amino acid catabolism and ketogenesis <xref rid="pone.0109617-Veldhorst1" ref-type="bibr">[24]</xref>, <xref rid="pone.0109617-WesterterpPlantenga1" ref-type="bibr">[25]</xref>. Hepatic lipid oxidation may also be stimulated by an increased bile acid production in response to high protein intake, a process that may also inhibit lipogenesis <xref rid="pone.0109617-Watanabe1" ref-type="bibr">[26]</xref>. Furthermore, protein-induced glucagon secretion inhibits de novo lipogenesis and stimulates hepatic ketogenesis <xref rid="pone.0109617-Torres1" ref-type="bibr">[27]</xref>, <xref rid="pone.0109617-Gannon1" ref-type="bibr">[28]</xref>.</p><p>On the other hand, previous studies showed that hyper- and eucaloric high-carbohydrate diets stimulated the synthesis of fatty acids from dietary glucose via de novo lipogenesis <xref rid="pone.0109617-Agius1" ref-type="bibr">[29]</xref>, <xref rid="pone.0109617-Hudgins1" ref-type="bibr">[30]</xref>, <xref rid="pone.0109617-Schwarz1" ref-type="bibr">[31]</xref>, <xref rid="pone.0109617-Hudgins2" ref-type="bibr">[32]</xref>. The carbohydrate-induced de novo lipogenesis correlated with plasma TG concentrations <xref rid="pone.0109617-Hudgins1" ref-type="bibr">[30]</xref>, <xref rid="pone.0109617-Schwarz1" ref-type="bibr">[31]</xref>. Increased IHTG deposition was shown to be the result of hepatic TG-synthesis exceeding the rate of its secretion into VLDL <xref rid="pone.0109617-Agius1" ref-type="bibr">[29]</xref>, <xref rid="pone.0109617-Hudgins1" ref-type="bibr">[30]</xref>. The relationship between high carbohydrate intake and increased VLDL-TG concentrations, possibly caused by stimulation of VLDL-TG production and inhibition of VLDL-TG clearance <xref rid="pone.0109617-Parks1" ref-type="bibr">[33]</xref>, may result in increases in hepatic TG concentrations, and subsequently in IHTG content <xref rid="pone.0109617-Schwarz1" ref-type="bibr">[31]</xref>. Protein supplementation has been observed to blunt the increase in IHTG content induced by short-term hypercaloric high-fructose intake in healthy subjects <xref rid="pone.0109617-Theytaz1" ref-type="bibr">[12]</xref>. Therefore, it is likely that the observed trend for a difference in IHTG content after the consumption of the HPLC compared with the HCLP diet may be the result of combined effects involving changes in protein and carbohydrate intake.</p><p>The strength of the present study was the application of an iso-energetic macronutrient intervention for a period that was long enough to reliably measure changes in IHTG content, thereby excluding the possible effects of metabolic disturbances and changes in body weight. Our healthy, non-obese subjects had a low IHTG content at baseline, which relates to a healthy metabolic function. This may exhibit a strong resistance to metabolic changes in response to dietary interventions when stimuli such as a high-fat or a high-fructose intake are absent <xref rid="pone.0109617-Bortolotti2" ref-type="bibr">[11]</xref>, <xref rid="pone.0109617-Theytaz1" ref-type="bibr">[12]</xref>. This indicates that high protein-low carbohydrate diets may be biologically less relevant for inducing a significant decrease in IHTG content in healthy subjects. Nevertheless, the observations of this study are relevant by suggesting that high protein-low carbohydrate diets may be beneficial for the prevention of metabolic disturbances in healthy subjects. Measurements of energy expenditure, body composition, body fat distribution including ectopic fat deposition, and metabolic function are needed to assess the translation of high-protein diets as a treatment strategy into a preventive measure. By addressing ectopic fat deposition in response to dietary interventions, this study adds to the discussion of the clinical relevance of dietary protein for the prevention of obesity. It would also be relevant to implement the measurement of IHTG content in studies assessing the effects of high-protein diets during body weight loss and weight maintenance in patients with metabolic disturbances.</p><p>To conclude, a HPLC vs. a HCLP diet has the potential to preserve vs. enlarge IHTG content in healthy non-obese subjects at a constant body weight.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0109617.s001"><label>Checklist S1</label><caption><p>
<bold>CONSORT Checklist.</bold>
</p><p>(DOC)</p></caption><media xlink:href="pone.0109617.s001.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0109617.s002"><label>Protocol S1</label><caption><p>
<bold>Study Protocol.</bold>
</p><p>(PDF)</p></caption><media xlink:href="pone.0109617.s002.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We acknowledge Prof. Dr. Joachim E. Wildberger for giving us the opportunity to perform the MRI and <sup>1</sup>H-MRS measurements at the Department of Radiology. We thank Dr. Vera B. Schrauwen-Hinderling for providing us a validated protocol for the determination of IHTG content by using MRI and <sup>1</sup>H-MRS, and for offering assistance with the post processing procedure, and Siti N. Wulan for her help in performing part of the studies.</p></ack><ref-list><title>References</title><ref id="pone.0109617-Acheson1"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Acheson</surname><given-names>KJ</given-names></name> (<year>2013</year>) <article-title>Diets for body weight control and health: the potential of changing the macronutrient composition</article-title>. <source>Eur J Clin Nutr</source>
<volume>67</volume>: <fpage>462</fpage>&#x02013;<lpage>466</lpage>.<pub-id pub-id-type="pmid">23187953</pub-id></mixed-citation></ref><ref id="pone.0109617-Wycherley1"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Wycherley</surname><given-names>TP</given-names></name>, <name><surname>Moran</surname><given-names>LJ</given-names></name>, <name><surname>Clifton</surname><given-names>PM</given-names></name>, <name><surname>Noakes</surname><given-names>M</given-names></name>, <name><surname>Brinkworth</surname><given-names>GD</given-names></name> (<year>2012</year>) <article-title>Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials</article-title>. <source>Am J Clin Nutr</source>
<volume>96</volume>: <fpage>1281</fpage>&#x02013;<lpage>1298</lpage>.<pub-id pub-id-type="pmid">23097268</pub-id></mixed-citation></ref><ref id="pone.0109617-Westerterp1"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Westerterp</surname><given-names>KR</given-names></name>, <name><surname>Verboeket-van de Venne</surname><given-names>WP</given-names></name>, <name><surname>Westerterp-Plantenga</surname><given-names>MS</given-names></name>, <name><surname>Velthuis-te Wierik</surname><given-names>EJ</given-names></name>, <name><surname>de Graaf</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>Dietary fat and body fat: an intervention study</article-title>. <source>Int J Obes Relat Metab Disord</source>
<volume>20</volume>: <fpage>1022</fpage>&#x02013;<lpage>1026</lpage>.<pub-id pub-id-type="pmid">8923159</pub-id></mixed-citation></ref><ref id="pone.0109617-Westerterp2"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Westerterp</surname><given-names>KR</given-names></name> (<year>2006</year>) <article-title>Perception, passive overfeeding and energy metabolism</article-title>. <source>Physiol Behav</source>
<volume>89</volume>: <fpage>62</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">16516250</pub-id></mixed-citation></ref><ref id="pone.0109617-Stubbs1"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Stubbs</surname><given-names>RJ</given-names></name>, <name><surname>Mazlan</surname><given-names>N</given-names></name>, <name><surname>Whybrow</surname><given-names>S</given-names></name> (<year>2001</year>) <article-title>Carbohydrates, appetite and feeding behavior in humans</article-title>. <source>J Nutr</source>
<volume>131</volume>: <fpage>2775S</fpage>&#x02013;<lpage>2781S</lpage>.<pub-id pub-id-type="pmid">11584105</pub-id></mixed-citation></ref><ref id="pone.0109617-Despres1"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Despres</surname><given-names>JP</given-names></name>, <name><surname>Lemieux</surname><given-names>I</given-names></name> (<year>2006</year>) <article-title>Abdominal obesity and metabolic syndrome</article-title>. <source>Nature</source>
<volume>444</volume>: <fpage>881</fpage>&#x02013;<lpage>887</lpage>.<pub-id pub-id-type="pmid">17167477</pub-id></mixed-citation></ref><ref id="pone.0109617-Lettner1"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Lettner</surname><given-names>A</given-names></name>, <name><surname>Roden</surname><given-names>M</given-names></name> (<year>2008</year>) <article-title>Ectopic fat and insulin resistance</article-title>. <source>Curr Diab Rep</source>
<volume>8</volume>: <fpage>185</fpage>&#x02013;<lpage>191</lpage>.<pub-id pub-id-type="pmid">18625114</pub-id></mixed-citation></ref><ref id="pone.0109617-Fabbrini1"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Fabbrini</surname><given-names>E</given-names></name>, <name><surname>Magkos</surname><given-names>F</given-names></name>, <name><surname>Mohammed</surname><given-names>BS</given-names></name>, <name><surname>Pietka</surname><given-names>T</given-names></name>, <name><surname>Abumrad</surname><given-names>NA</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>106</volume>: <fpage>15430</fpage>&#x02013;<lpage>15435</lpage>.<pub-id pub-id-type="pmid">19706383</pub-id></mixed-citation></ref><ref id="pone.0109617-Magkos1"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Magkos</surname><given-names>F</given-names></name>, <name><surname>Fabbrini</surname><given-names>E</given-names></name>, <name><surname>Mohammed</surname><given-names>BS</given-names></name>, <name><surname>Patterson</surname><given-names>BW</given-names></name>, <name><surname>Klein</surname><given-names>S</given-names></name> (<year>2010</year>) <article-title>Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction</article-title>. <source>Obesity (Silver Spring)</source>
<volume>18</volume>: <fpage>1510</fpage>&#x02013;<lpage>1515</lpage>.<pub-id pub-id-type="pmid">20395947</pub-id></mixed-citation></ref><ref id="pone.0109617-Bortolotti1"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Bortolotti</surname><given-names>M</given-names></name>, <name><surname>Maiolo</surname><given-names>E</given-names></name>, <name><surname>Corazza</surname><given-names>M</given-names></name>, <name><surname>Van Dijke</surname><given-names>E</given-names></name>, <name><surname>Schneiter</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients</article-title>. <source>Clin Nutr</source>
<volume>30</volume>: <fpage>494</fpage>&#x02013;<lpage>498</lpage>.<pub-id pub-id-type="pmid">21288612</pub-id></mixed-citation></ref><ref id="pone.0109617-Bortolotti2"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Bortolotti</surname><given-names>M</given-names></name>, <name><surname>Kreis</surname><given-names>R</given-names></name>, <name><surname>Debard</surname><given-names>C</given-names></name>, <name><surname>Cariou</surname><given-names>B</given-names></name>, <name><surname>Faeh</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>High protein intake reduces intrahepatocellular lipid deposition in humans</article-title>. <source>Am J Clin Nutr</source>
<volume>90</volume>: <fpage>1002</fpage>&#x02013;<lpage>1010</lpage>.<pub-id pub-id-type="pmid">19710199</pub-id></mixed-citation></ref><ref id="pone.0109617-Theytaz1"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Theytaz</surname><given-names>F</given-names></name>, <name><surname>Noguchi</surname><given-names>Y</given-names></name>, <name><surname>Egli</surname><given-names>L</given-names></name>, <name><surname>Campos</surname><given-names>V</given-names></name>, <name><surname>Buehler</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Effects of supplementation with essential amino acids on intrahepatic lipid concentrations during fructose overfeeding in humans</article-title>. <source>Am J Clin Nutr</source>
<volume>96</volume>: <fpage>1008</fpage>&#x02013;<lpage>1016</lpage>.<pub-id pub-id-type="pmid">23034968</pub-id></mixed-citation></ref><ref id="pone.0109617-Baecke1"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Baecke</surname><given-names>JA</given-names></name>, <name><surname>Burema</surname><given-names>J</given-names></name>, <name><surname>Frijters</surname><given-names>JE</given-names></name> (<year>1982</year>) <article-title>A short questionnaire for the measurement of habitual physical activity in epidemiological studies</article-title>. <source>Am J Clin Nutr</source>
<volume>36</volume>: <fpage>936</fpage>&#x02013;<lpage>942</lpage>.<pub-id pub-id-type="pmid">7137077</pub-id></mixed-citation></ref><ref id="pone.0109617-Philippaerts1"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Philippaerts</surname><given-names>RM</given-names></name>, <name><surname>Matton</surname><given-names>L</given-names></name>, <name><surname>Wijndaele</surname><given-names>K</given-names></name>, <name><surname>Balduck</surname><given-names>AL</given-names></name>, <name><surname>De Bourdeaudhuij</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Validity of a physical activity computer questionnaire in 12- to 18-year-old boys and girls</article-title>. <source>Int J Sports Med</source>
<volume>27</volume>: <fpage>131</fpage>&#x02013;<lpage>136</lpage>.<pub-id pub-id-type="pmid">16475059</pub-id></mixed-citation></ref><ref id="pone.0109617-Harris1"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Harris</surname><given-names>JA</given-names></name>, <name><surname>Benedict</surname><given-names>FG</given-names></name> (<year>1918</year>) <article-title>A Biometric Study of Human Basal Metabolism</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>4</volume>: <fpage>370</fpage>&#x02013;<lpage>373</lpage>.<pub-id pub-id-type="pmid">16576330</pub-id></mixed-citation></ref><ref id="pone.0109617-Westerterp3"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Westerterp</surname><given-names>KR</given-names></name>, <name><surname>Wouters</surname><given-names>L</given-names></name>, <name><surname>van Marken Lichtenbelt</surname><given-names>WD</given-names></name> (<year>1995</year>) <article-title>The Maastricht protocol for the measurement of body composition and energy expenditure with labeled water</article-title>. <source>Obes Res</source>
<volume>3</volume> Suppl 1<fpage>49</fpage>&#x02013;<lpage>57</lpage>.</mixed-citation></ref><ref id="pone.0109617-Hamilton1"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Hamilton</surname><given-names>G</given-names></name>, <name><surname>Yokoo</surname><given-names>T</given-names></name>, <name><surname>Bydder</surname><given-names>M</given-names></name>, <name><surname>Cruite</surname><given-names>I</given-names></name>, <name><surname>Schroeder</surname><given-names>ME</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>In vivo characterization of the liver fat (1)H MR spectrum</article-title>. <source>NMR Biomed</source>
<volume>24</volume>: <fpage>784</fpage>&#x02013;<lpage>790</lpage>.<pub-id pub-id-type="pmid">21834002</pub-id></mixed-citation></ref><ref id="pone.0109617-Szczepaniak1"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Szczepaniak</surname><given-names>LS</given-names></name>, <name><surname>Nurenberg</surname><given-names>P</given-names></name>, <name><surname>Leonard</surname><given-names>D</given-names></name>, <name><surname>Browning</surname><given-names>JD</given-names></name>, <name><surname>Reingold</surname><given-names>JS</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population</article-title>. <source>Am J Physiol Endocrinol Metab</source>
<volume>288</volume>: <fpage>E462</fpage>&#x02013;<lpage>468</lpage>.<pub-id pub-id-type="pmid">15339742</pub-id></mixed-citation></ref><ref id="pone.0109617-SchrauwenHinderling1"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Schrauwen-Hinderling</surname><given-names>VB</given-names></name>, <name><surname>van Loon</surname><given-names>LJ</given-names></name>, <name><surname>Koopman</surname><given-names>R</given-names></name>, <name><surname>Nicolay</surname><given-names>K</given-names></name>, <name><surname>Saris</surname><given-names>WH</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Intramyocellular lipid content is increased after exercise in nonexercising human skeletal muscle</article-title>. <source>J Appl Physiol (1985)</source>
<volume>95</volume>: <fpage>2328</fpage>&#x02013;<lpage>2332</lpage>.<pub-id pub-id-type="pmid">12923116</pub-id></mixed-citation></ref><ref id="pone.0109617-Naressi1"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Naressi</surname><given-names>A</given-names></name>, <name><surname>Couturier</surname><given-names>C</given-names></name>, <name><surname>Devos</surname><given-names>JM</given-names></name>, <name><surname>Janssen</surname><given-names>M</given-names></name>, <name><surname>Mangeat</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Java-based graphical user interface for the MRUI quantitation package</article-title>. <source>MAGMA</source>
<volume>12</volume>: <fpage>141</fpage>&#x02013;<lpage>152</lpage>.<pub-id pub-id-type="pmid">11390270</pub-id></mixed-citation></ref><ref id="pone.0109617-Vanhamme1"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Vanhamme</surname><given-names>L</given-names></name>, <name><surname>van den Boogaart</surname><given-names>A</given-names></name>, <name><surname>Van Huffel</surname><given-names>S</given-names></name> (<year>1997</year>) <article-title>Improved method for accurate and efficient quantification of MRS data with use of prior knowledge</article-title>. <source>J Magn Reson</source>
<volume>129</volume>: <fpage>35</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">9405214</pub-id></mixed-citation></ref><ref id="pone.0109617-Boesch1"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Boesch</surname><given-names>C</given-names></name>, <name><surname>Slotboom</surname><given-names>J</given-names></name>, <name><surname>Hoppeler</surname><given-names>H</given-names></name>, <name><surname>Kreis</surname><given-names>R</given-names></name> (<year>1997</year>) <article-title>In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy</article-title>. <source>Magn Reson Med</source>
<volume>37</volume>: <fpage>484</fpage>&#x02013;<lpage>493</lpage>.<pub-id pub-id-type="pmid">9094069</pub-id></mixed-citation></ref><ref id="pone.0109617-Schick1"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Schick</surname><given-names>F</given-names></name>, <name><surname>Eismann</surname><given-names>B</given-names></name>, <name><surname>Jung</surname><given-names>WI</given-names></name>, <name><surname>Bongers</surname><given-names>H</given-names></name>, <name><surname>Bunse</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>1993</year>) <article-title>Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue</article-title>. <source>Magn Reson Med</source>
<volume>29</volume>: <fpage>158</fpage>&#x02013;<lpage>167</lpage>.<pub-id pub-id-type="pmid">8429779</pub-id></mixed-citation></ref><ref id="pone.0109617-Veldhorst1"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Veldhorst</surname><given-names>MA</given-names></name>, <name><surname>Westerterp-Plantenga</surname><given-names>MS</given-names></name>, <name><surname>Westerterp</surname><given-names>KR</given-names></name> (<year>2009</year>) <article-title>Gluconeogenesis and energy expenditure after a high-protein, carbohydrate-free diet</article-title>. <source>Am J Clin Nutr</source>
<volume>90</volume>: <fpage>519</fpage>&#x02013;<lpage>526</lpage>.<pub-id pub-id-type="pmid">19640952</pub-id></mixed-citation></ref><ref id="pone.0109617-WesterterpPlantenga1"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Westerterp-Plantenga</surname><given-names>MS</given-names></name>, <name><surname>Lemmens</surname><given-names>SG</given-names></name>, <name><surname>Westerterp</surname><given-names>KR</given-names></name> (<year>2012</year>) <article-title>Dietary protein - its role in satiety, energetics, weight loss and health</article-title>. <source>Br J Nutr</source>
<volume>108</volume> Suppl 2<fpage>S105</fpage>&#x02013;<lpage>112</lpage>.<pub-id pub-id-type="pmid">23107521</pub-id></mixed-citation></ref><ref id="pone.0109617-Watanabe1"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Watanabe</surname><given-names>M</given-names></name>, <name><surname>Houten</surname><given-names>SM</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Moschetta</surname><given-names>A</given-names></name>, <name><surname>Mangelsdorf</surname><given-names>DJ</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c</article-title>. <source>J Clin Invest</source>
<volume>113</volume>: <fpage>1408</fpage>&#x02013;<lpage>1418</lpage>.<pub-id pub-id-type="pmid">15146238</pub-id></mixed-citation></ref><ref id="pone.0109617-Torres1"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Torres</surname><given-names>N</given-names></name>, <name><surname>Tovar</surname><given-names>AR</given-names></name> (<year>2007</year>) <article-title>The role of dietary protein on lipotoxicity</article-title>. <source>Nutr Rev</source>
<volume>65</volume>: <fpage>S64</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">17605316</pub-id></mixed-citation></ref><ref id="pone.0109617-Gannon1"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Gannon</surname><given-names>MC</given-names></name>, <name><surname>Nuttall</surname><given-names>JA</given-names></name>, <name><surname>Damberg</surname><given-names>G</given-names></name>, <name><surname>Gupta</surname><given-names>V</given-names></name>, <name><surname>Nuttall</surname><given-names>FQ</given-names></name> (<year>2001</year>) <article-title>Effect of protein ingestion on the glucose appearance rate in people with type 2 diabetes</article-title>. <source>J Clin Endocrinol Metab</source>
<volume>86</volume>: <fpage>1040</fpage>&#x02013;<lpage>1047</lpage>.<pub-id pub-id-type="pmid">11238483</pub-id></mixed-citation></ref><ref id="pone.0109617-Agius1"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Agius</surname><given-names>L</given-names></name> (<year>2013</year>) <article-title>High-carbohydrate diets induce hepatic insulin resistance to protect the liver from substrate overload</article-title>. <source>Biochem Pharmacol</source>
<volume>85</volume>: <fpage>306</fpage>&#x02013;<lpage>312</lpage>.<pub-id pub-id-type="pmid">23022226</pub-id></mixed-citation></ref><ref id="pone.0109617-Hudgins1"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Hudgins</surname><given-names>LC</given-names></name>, <name><surname>Hellerstein</surname><given-names>MK</given-names></name>, <name><surname>Seidman</surname><given-names>CE</given-names></name>, <name><surname>Neese</surname><given-names>RA</given-names></name>, <name><surname>Tremaroli</surname><given-names>JD</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects</article-title>. <source>J Lipid Res</source>
<volume>41</volume>: <fpage>595</fpage>&#x02013;<lpage>604</lpage>.<pub-id pub-id-type="pmid">10744780</pub-id></mixed-citation></ref><ref id="pone.0109617-Schwarz1"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Schwarz</surname><given-names>JM</given-names></name>, <name><surname>Neese</surname><given-names>RA</given-names></name>, <name><surname>Turner</surname><given-names>S</given-names></name>, <name><surname>Dare</surname><given-names>D</given-names></name>, <name><surname>Hellerstein</surname><given-names>MK</given-names></name> (<year>1995</year>) <article-title>Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection</article-title>. <source>J Clin Invest</source>
<volume>96</volume>: <fpage>2735</fpage>&#x02013;<lpage>2743</lpage>.<pub-id pub-id-type="pmid">8675642</pub-id></mixed-citation></ref><ref id="pone.0109617-Hudgins2"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Hudgins</surname><given-names>LC</given-names></name>, <name><surname>Hellerstein</surname><given-names>M</given-names></name>, <name><surname>Seidman</surname><given-names>C</given-names></name>, <name><surname>Neese</surname><given-names>R</given-names></name>, <name><surname>Diakun</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet</article-title>. <source>J Clin Invest</source>
<volume>97</volume>: <fpage>2081</fpage>&#x02013;<lpage>2091</lpage>.<pub-id pub-id-type="pmid">8621798</pub-id></mixed-citation></ref><ref id="pone.0109617-Parks1"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Parks</surname><given-names>EJ</given-names></name>, <name><surname>Hellerstein</surname><given-names>MK</given-names></name> (<year>2000</year>) <article-title>Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms</article-title>. <source>Am J Clin Nutr</source>
<volume>71</volume>: <fpage>412</fpage>&#x02013;<lpage>433</lpage>.<pub-id pub-id-type="pmid">10648253</pub-id></mixed-citation></ref></ref-list></back></article>